Biocon Limited (BIOCON:NSE) Annual Income Statement ()
BIOCON:NSE Quarterly Financials ()
Frequently Asked Questions About Biocon Limited (BIOCON:NSE) Stock
Biocon Limited's (BIOCON:NSE) last reported annual revenue was INR 111.74 Billion.
Biocon Limited's (BIOCON:NSE) annual revenue growth rate based on the revenue reported in the past 5 years is : 22.94%
Biocon Limited's(BIOCON:NSE) is profitable as of its last reported annual financials.
The net profit margin for Biocon Limited's(BIOCON:NSE) from its laster reported year is 4.14%
The return on equity (ROE) for Biocon Limited's(BIOCON:NSE) from its last reported annual financials is : 4.07%
The return on assets (ROA) for Biocon Limited's(BIOCON:NSE) from its last reported annual financials is : 3.00%
The return on invested capital (ROIC) for Biocon Limited's(BIOCON:NSE) from its last reported annual financials is : 5.35%
The Debt to Equity ratio for Biocon Limited's(BIOCON:NSE) from its last reported annual financials is : 85.58%
The dividend yield for Biocon Limited's(BIOCON:NSE) from its laster reported year is 0.48%
Biocon Limited's(BIOCON:NSE) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Underpriced on free cash flow basis
The stock is trading low compared to its peers on a price to free cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
Superior Dividend Growth
This stock has shown top quartile dividend growth in the previous 5 years compared to its sector
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for BIOCON:NSE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
